From: |
|
Alison Bunce - Medicines and Healthcare Products Regulatory Agency
|
|
|
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Trusts (England) - Medical Director
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Clinical Commissioning Groups
- NHS Foundation Trusts (England) - Chief Executive
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Director of Public Health
- NHS Trusts (England) - Chief Executive
|
Title: |
|
DRUG ALERT CLASS 4, FOR INFORMATION, MARTINDALE PHARMA, PHENOBARBITAL 30MG/ML INJECTION
|
Broadcast content: |
|
Martindale Pharma has informed us that the barcode on some batches of the above product is incorrect and should not be used for wholesaling or dispensing activities.
Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts We understand that this product is used in hospitals and is unlikely to be used in General Practice or Community Pharmacy. Please do not send this communication to Community Pharmacists or to GPs unless they are known to use the product outside the hospital setting.
|
|
Cascade to: |
|
- #ACCIDENTEMERGENCY#
- #HospitalPharmacy#
|